Clinical Trials Browser

Phase 1/2 × Recruiting × Dasatinib × Clear all

Prostate Cancer Recurrent

NCT05751044 2025-09-16

HEM-iSMART B

Leukemia, Recurrence, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT04835584 2022-03-21

KRT-232 and TKI Study in Chronic Myeloid Leukemia

Phase 1/2 Recruiting

109 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Clinical Trials

COAST

HEM-iSMART B

KRT-232 and TKI Study in Chronic Myeloid Leukemia